The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells - PubMed (original) (raw)
The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells
Jie Wang et al. Int J Oncol. 2016 Jul.
Abstract
NF-κB subunits play important roles in carcinogenesis of a variety of human malignancies and response to cancer therapy; however, the contribution of an individual subunit has not been thoroughly defined. Constitutive activation of the canonical NF-κB subunit is a critical event in prostate carcinogenesis. Recent findings point out that RelB, which contributes to the non-canonical NF-κB activity, functions importantly in the prostate cancer progression. Here, we investigated systemically the functional roles of RelB in prostate cancer and examine its significance as a therapeutic target. Targeting RelB using short hairpin RNA approach in androgen-independent DU145 prostate cancer cells interfered with various biological behaviors of cells. We observed that RelB knockdown inhibited prostate cancer cell growth, migration, and invasion, and enhanced proteasome inhibitor sensitivity. The altered expression of anti-apoptotic gene Bcl-2 played critical roles in regulating both spontaneous and radiation-induced apoptosis in the presence of RelB knockdown. For the first time, we showed that RelB knockdown significantly attenuated the migration and invasion of DU145 prostate cancer cells, due to the reduction of integrin β-1. Collectively, we provided evidence that RelB functioned as an oncogene in prostate cancer. Developing a RelB-targeted therapeutic intervention, is valuable in treating advanced, metastatic prostate cancer.
Similar articles
- Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines.
Guo F, Kang S, Zhou P, Guo L, Ma L, Hou J. Guo F, et al. Mol Immunol. 2011 Oct;49(1-2):8-17. doi: 10.1016/j.molimm.2011.07.013. Mol Immunol. 2011. PMID: 21856005 - [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
Ma L, Shen YY, Zhou P, Zhou J, Guo F. Ma L, et al. Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):165-8. doi: 10.3760/cma.j.issn.0253-3766.2012.03.002. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780967 Chinese. - RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.
Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A, St Clair WH. Xu Y, et al. Cancer Res. 2009 Apr 15;69(8):3267-71. doi: 10.1158/0008-5472.CAN-08-4635. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351823 Free PMC article. - RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
Holley AK, Xu Y, St Clair DK, St Clair WH. Holley AK, et al. Ann N Y Acad Sci. 2010 Jul;1201:129-36. doi: 10.1111/j.1749-6632.2010.05613.x. Ann N Y Acad Sci. 2010. PMID: 20649549 Free PMC article. Review. - RelB: an outlier in leukocyte biology.
Millet P, McCall C, Yoza B. Millet P, et al. J Leukoc Biol. 2013 Nov;94(5):941-51. doi: 10.1189/jlb.0513305. Epub 2013 Aug 6. J Leukoc Biol. 2013. PMID: 23922380 Free PMC article. Review.
Cited by
- cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
Beernaert B, Parkes EE. Beernaert B, et al. Biochem Soc Trans. 2023 Apr 26;51(2):539-555. doi: 10.1042/BST20220838. Biochem Soc Trans. 2023. PMID: 36876871 Free PMC article. Review. - Enhanced Inhibition of Cancer Cell Migration by a Planar Catechin Analog.
Ito H, Shoji Y, Matsumoto KI, Fukuhara K, Nakanishi I. Ito H, et al. ACS Med Chem Lett. 2024 Jan 10;15(2):310-313. doi: 10.1021/acsmedchemlett.3c00499. eCollection 2024 Feb 8. ACS Med Chem Lett. 2024. PMID: 38352823 - Chromosomal instability drives metastasis through a cytosolic DNA response.
Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, Duran M, Pauli C, Shaw C, Chadalavada K, Rajasekhar VK, Genovese G, Venkatesan S, Birkbak NJ, McGranahan N, Lundquist M, LaPlant Q, Healey JH, Elemento O, Chung CH, Lee NY, Imielenski M, Nanjangud G, Pe'er D, Cleveland DW, Powell SN, Lammerding J, Swanton C, Cantley LC. Bakhoum SF, et al. Nature. 2018 Jan 25;553(7689):467-472. doi: 10.1038/nature25432. Epub 2018 Jan 17. Nature. 2018. PMID: 29342134 Free PMC article. - The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.
Oseni SO, Naar C, Pavlović M, Asghar W, Hartmann JX, Fields GB, Esiobu N, Kumi-Diaka J. Oseni SO, et al. Cancers (Basel). 2023 Jun 8;15(12):3110. doi: 10.3390/cancers15123110. Cancers (Basel). 2023. PMID: 37370720 Free PMC article. Review. - Role of Metabolism and Metabolic Pathways in Prostate Cancer.
Wanjari UR, Mukherjee AG, Gopalakrishnan AV, Murali R, Dey A, Vellingiri B, Ganesan R. Wanjari UR, et al. Metabolites. 2023 Jan 25;13(2):183. doi: 10.3390/metabo13020183. Metabolites. 2023. PMID: 36837801 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical